Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R I Abels

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Acta Haematologica|January 1, 1992
Recombinant human erythropoietin in the treatment of the anaemia of cancerR I Abels
Seminars in Oncology|June 1, 1992
Use of recombinant human erythropoietin in the treatment of anemia in patients who have cancerR I Abels
Experimental Hematology|September 1, 1991
Erythropoietin: evolving clinical applicationsR I Abels, S A Rudnick
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Benefits of epoetin alfa therapy in anemic cancer patients receiving chemotherapyD H Henry, R I Abels
Seminars in Oncology|April 1, 1994
Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double-blind and open-label follow-up studiesD H Henry, R I Abels
The Journal of Bone and Joint Surgery. American Volume|January 1, 1996
The effects of recombinant human erythropoietin on perioperative transfusion requirements in patients having a major orthopaedic operation. The American Erythropoietin Study GroupP M Faris, M A Ritter, R I Abels
Blood|October 1, 1991
Pharmacologic doses of recombinant human erythropoietin in the treatment of myelodysplastic syndromesR S Stein, R I Abels, S B Krantz
The Journal of Allergy and Clinical Immunology|November 1, 1978
Efficacy of intravenous pretesting and antihistamine prophylaxis in radiocontrast media--sensitive patientsM W Yocum, A M Heller, R I Abels
Lancet (London, England)|September 17, 1988
Subcutaneous erythropoietinK J Boughton, R I Abels, S A Rudnick
Archives of Internal Medicine|December 13, 1993
Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall resultsJ P Phair, R I Abels, M V McNeill, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Acta Haematologica|January 1, 1992
Recombinant human erythropoietin in the treatment of the anaemia of cancerR I Abels
Seminars in Oncology|June 1, 1992
Use of recombinant human erythropoietin in the treatment of anemia in patients who have cancerR I Abels
Experimental Hematology|September 1, 1991
Erythropoietin: evolving clinical applicationsR I Abels, S A Rudnick
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Benefits of epoetin alfa therapy in anemic cancer patients receiving chemotherapyD H Henry, R I Abels
Seminars in Oncology|April 1, 1994
Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double-blind and open-label follow-up studiesD H Henry, R I Abels
The Journal of Bone and Joint Surgery. American Volume|January 1, 1996
The effects of recombinant human erythropoietin on perioperative transfusion requirements in patients having a major orthopaedic operation. The American Erythropoietin Study GroupP M Faris, M A Ritter, R I Abels
Blood|October 1, 1991
Pharmacologic doses of recombinant human erythropoietin in the treatment of myelodysplastic syndromesR S Stein, R I Abels, S B Krantz
The Journal of Allergy and Clinical Immunology|November 1, 1978
Efficacy of intravenous pretesting and antihistamine prophylaxis in radiocontrast media--sensitive patientsM W Yocum, A M Heller, R I Abels
Lancet (London, England)|September 17, 1988
Subcutaneous erythropoietinK J Boughton, R I Abels, S A Rudnick
Archives of Internal Medicine|December 13, 1993
Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall resultsJ P Phair, R I Abels, M V McNeill, et al.
Pageof 3